These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18647623)

  • 1. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies.
    Tarnopolsky MA
    Adv Drug Deliv Rev; 2008; 60(13-14):1561-7. PubMed ID: 18647623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management.
    Kidd PM
    Altern Med Rev; 2005 Dec; 10(4):268-93. PubMed ID: 16366737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction.
    Orsucci D; Filosto M; Siciliano G; Mancuso M
    Nutr Rev; 2009 Aug; 67(8):427-38. PubMed ID: 19674340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the senescent heart to stress: clinical therapeutic strategies and quest for mitochondrial predictors of biological age.
    Rosenfeldt F; Miller F; Nagley P; Hadj A; Marasco S; Quick D; Sheeran F; Wowk M; Pepe S
    Ann N Y Acad Sci; 2004 Jun; 1019():78-84. PubMed ID: 15246998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and chronic disease: treatment with natural supplements.
    Nicolson GL
    Altern Ther Health Med; 2014; 20 Suppl 1():18-25. PubMed ID: 24473982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional diagnostics in mitochondrial diseases.
    Siciliano G; Volpi L; Piazza S; Ricci G; Mancuso M; Murri L
    Biosci Rep; 2007 Jun; 27(1-3):53-67. PubMed ID: 17492503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.
    Tarnopolsky MA; Beal MF
    Ann Neurol; 2001 May; 49(5):561-74. PubMed ID: 11357946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid replacement therapy: a nutraceutical approach for reducing cancer-associated fatigue and the adverse effects of cancer therapy while restoring mitochondrial function.
    Nicolson GL
    Cancer Metastasis Rev; 2010 Sep; 29(3):543-52. PubMed ID: 20717704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional cofactor treatment in mitochondrial disorders.
    Marriage B; Clandinin MT; Glerum DM
    J Am Diet Assoc; 2003 Aug; 103(8):1029-38. PubMed ID: 12891154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial medicine: entering the era of treatment.
    Koene S; Smeitink J
    J Intern Med; 2009 Feb; 265(2):193-209. PubMed ID: 19192036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial diseases: therapeutic approaches.
    DiMauro S; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):125-37. PubMed ID: 17486439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
    Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
    Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine].
    González-Pérez O; Moy-López NA; Guzmán-Muñiz J
    Rev Invest Clin; 2008; 60(1):58-67. PubMed ID: 18589588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal micronutrients delay mitochondrial decay and age-associated diseases.
    Ames BN
    Mech Ageing Dev; 2010; 131(7-8):473-9. PubMed ID: 20420847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Two patients with mitochondrial respiratory chain disease].
    Bangma HR; Smit GP; Kuks JB; Grevink RG; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 2008 Oct; 152(42):2298-301. PubMed ID: 19009881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.